Stock listing

NYSE:KG King Pharmaceuticals Inc Stock

Follow King Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NYSE:KG

$14.24 USD

Close on Feb 28, 2011 · No longer trades

Jun 26, 1998 to last close +1.7% · monthly closes, Jun 26, 1998 – Feb 28, 2011
Lowest – highest close
$6.13 – $65.25 USDSince Jun 26, 1998 · lowest Mar 6, 2009 · highest Dec 3, 1999

Delisted NYSE:KG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:KG
Asset type
Stock
Exchange
NYSE
Currency
USD

King Pharmaceuticals Inc on 6ix

Decks
1 deck · latest Jul 26, 2004

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 6, 2026−1.0%
Quarter to Jun 30, 2026Aug 7, 2026−3.5%
Quarter to Mar 31, 2026May 8, 2026+4.6%
Quarter to Sep 30, 2025Nov 5, 2025−16.7%
Quarter to Mar 31, 2025May 12, 20250.0%
Quarter to Dec 31, 2024Mar 10, 2025+22.5%
Quarter to Sep 30, 2024Nov 12, 2024−9.3%
Quarter to Jun 30, 2024Aug 8, 2024+1.2%
Quarter to Mar 31, 2024May 9, 2024+1.9%
Quarter to Dec 31, 2023Mar 12, 2024+1.4%
All 20 quarters
QuarterResultsShare move
Quarter to Sep 30, 2023Nov 8, 2023−6.6%
Quarter to Jun 30, 2023Aug 8, 2023−7.8%
Quarter to Mar 31, 2023May 9, 2023−8.9%
Quarter to Dec 31, 2022Mar 15, 2023−7.6%
Quarter to Sep 30, 2022Nov 9, 2022+9.9%
Quarter to Jun 30, 2022Aug 9, 2022+4.4%
Quarter to Mar 31, 2022May 10, 2022+9.3%
Quarter to Dec 31, 2021Mar 14, 2022+13.8%
Quarter to Sep 30, 2021Nov 9, 2021−9.1%
Quarter to Jun 30, 2021Aug 9, 2021−4.4%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (July 2004)Merger or acquisition18 slidesJul 26, 2004

Open Decks

Cap table

Built by 6ix from King Pharmaceuticals Inc’s releases

Common shares
7,824,030
Fully diluted
7,824,030

Fully diluted

LineShares
Common shares7,824,030

Share count over time

CountShares
Nov 22, 20267,824,030

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Douglas E Giordano
Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Panacea Acquisition II Corp (Director · Apr 6, 2021 – Apr 6, 2021 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); Viatris Inc. (Director · Aug 6, 2020 – Nov 16, 2020 · Past); ICU Medical, Inc. (Director · Feb 3, 2017 – Feb 3, 2017 · Past); Zoetis Inc. (Director · Jan 31, 2013 – Feb 6, 2013 · Past); Icagen Inc (Director · Sep 22, 2011 – Sep 22, 2011 · Past); Encysive Pharmaceuticals Inc (Director · Apr 3, 2008 – Apr 3, 2008 · Past)
Director · Jan 31, 2011 – Jan 31, 2011 · Past
Kevin S Crutchfield
Other companies: Intrepid Potash, Inc (Chief Executive Officer, Director · Since at least Dec 2, 2024); Compass Minerals Intl Inc (President and CEO, Director · May 7, 2019 – Jan 17, 2024 · Past); Alpha Metallurgical Resources, Inc. (Chief Executive Officer, Director · Nov 9, 2018 – May 2, 2019 · Past); Rice Energy (Director · Jan 24, 2014 – Nov 6, 2014 · Past); Coeur Mining, Inc. (Director · May 14, 2013 – Feb 5, 2019 · Past); Alpha Natural Resources Inc (Chairman and CEO, Director · Dec 31, 2005 – Mar 13, 2015 · Past)
Director · Feb 8, 2010 – Jan 31, 2011 · Past
Brian A Markison
Other companies: Organogenesis Holdings Inc. (Director · Oct 7, 2016 – Dec 10, 2018 · Past); Lantheus Holdings, Inc. (CEO, Director · Jun 24, 2015 – Mar 5, 2025 · Past); Alere Inc (Director · Aug 14, 2013 – Oct 3, 2017 · Past); Altimmune, Inc. (Director · Sep 22, 2011 – Dec 31, 2014 · Past); Immunomedics Inc (Director · Aug 24, 2006 – Nov 20, 2017 · Past)
President and CEO, Director · Mar 20, 2006 – Feb 28, 2011 · Past
Jeffrey Bailey
Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Aug 18, 2023); BioDelivery Sciences International Inc (Chief Executive Officer, Director · Mar 9, 2020 – Mar 22, 2022 · Past); Rein Therapeutics, Inc. (Director · Mar 15, 2018 – Jun 17, 2022 · Past); Lantheus Holdings, Inc. (CEO and President, Director · Jun 24, 2015 – Aug 31, 2015 · Past); Landauer Inc (Director · Apr 17, 2015 – Oct 19, 2017 · Past)
Chief Commercial Officer · Aug 30, 2010 – Mar 1, 2011 · Past
Earnest W Deavenport Jr
Other companies: Zep Inc (Director · Oct 31, 2007 – Nov 1, 2010 · Past); Regions Financial Corporation (Director · Nov 4, 2006 – Jan 15, 2010 · Past); Acuity Inc. (Director · Jan 12, 2006 – Aug 1, 2007 · Past); Amsouth Bancorporation (Director · Jan 3, 2006 – Nov 4, 2006 · Past)
Director · Apr 28, 2006 – Nov 11, 2010 · Past
Bryan Supran
Other companies: Alnylam Pharmaceuticals, Inc. (Chief Legal Officer · Since at least Sep 15, 2025); Viatris Inc. (Director · Aug 6, 2020 – Nov 16, 2020 · Past); Icagen Inc (Director · Sep 22, 2011 – Sep 22, 2011 · Past)
Director · Jan 31, 2011 – Jan 31, 2011 · Past
Derace L Schaffer
Other companies: Lantheus Holdings, Inc. (Director · Mar 4, 2016 – Mar 3, 2020 · Past); American Caresource Holdings Inc (Director · Jul 20, 2010 – Jun 14, 2012 · Past); Altimmune, Inc. (Director · May 17, 2010 – Dec 28, 2017 · Past)
Director · May 14, 2010 – Jan 31, 2011 · Past
Eric Carter
Other companies: AEON Biopharma, Inc. (Board Member · Since at least Jul 21, 2023); Alder BioPharmaceuticals Inc (Interim Chief Medical Officer · Apr 23, 2018 – Apr 23, 2018 · Past); Adverum Biotechnologies Inc (Director · Sep 7, 2017 – Jun 23, 2020 · Past)
Chief Science Officer · Jan 24, 2007 – Mar 1, 2011 · Past
Kristin C. Peck
Other companies: BlackRock, Inc. (Director · Since at least Sep 28, 2021); Zoetis Inc. (President and Chief Executive Officer · Since at least Jan 31, 2013); Pfizer, Inc. (Executive Vice President · Apr 1, 2010 – Oct 31, 2012 · Past)
Director · Jan 31, 2011 – Jan 31, 2011 · Past
Ted G Wood
Other companies: Alpha Natural Resources Inc (Director · Jan 25, 2006 – May 17, 2012 · Past); POZEN Inc (Director · Jan 3, 2006 – Jan 3, 2006 · Past)
Director · Apr 28, 2006 – Feb 28, 2011 · Past
All 22 people
PersonSeat
Charles Moyer
Other companies: Capitala Finance Corp (Director · Sep 24, 2013 – May 20, 2015 · Past)
Director · Apr 28, 2006 – Feb 28, 2011 · Past
David Reid
Other companies: Encysive Pharmaceuticals Inc (Director · Apr 3, 2008 – Apr 3, 2008 · Past)
Director · Jan 31, 2011 – Jan 31, 2011 · Past
Elizabeth M Greetham
Other companies: Ligand Pharmaceuticals Incorporated (Director · Mar 1, 2007 – May 29, 2008 · Past)
Director · Apr 28, 2006 – Feb 28, 2011 · Past
James W Elrod
Other companies: Tivity Health Inc (VP, General Counsel · Feb 21, 2011 – Mar 3, 2011 · Past)
Chief Legal Officer, A. Sec. · Feb 21, 2006 – Feb 15, 2011 · Past
Joseph Squicciarino
Other companies: Zep Inc (Director · Sep 29, 2008 – Jun 26, 2015 · Past)
Chief Financial Officer · Dec 31, 2008 – Mar 1, 2011 · Past
Matthew Lepore
Other companies: Air Products and Chemicals, Inc. (EVP & General Counsel · Since at least Aug 18, 2025)
Director · Jan 31, 2011 – Jan 31, 2011 · Past
Philip A Incarnati
Other companies: Theragenics Corp (Director · May 9, 2006 – May 19, 2006 · Past)
Director · Nov 1, 2006 – Oct 7, 2010 · Past
D Gregory RookerDirector · Jan 11, 2006 – Nov 29, 2010 · Past
Eric J BrucePresident, Animal Health · Mar 20, 2006 – Feb 28, 2011 · Past
James E GreenExec Vice Pres Corp Affairs · Mar 20, 2006 – Mar 20, 2009 · Past
Philip M PfefferDirector · Apr 28, 2006 – Apr 28, 2006 · Past
Stephen J AndrzejewskiChief Commercial Officer · Mar 20, 2006 – Mar 22, 2010 · Past

Open People

Log in to ask 6ix AI your own questions about King Pharmaceuticals Inc.